Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis
- 1 November 2018
- Vol. 154 (5) , 1070-1082
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of War (W81XWH-12-1-0578)
- National Heart, Lung, and Blood Institute (W81XWH-12-1-0578)
- National Institutes of Health (W81XWH-12-1-0578)
This publication has 42 references indexed in Scilit:
- The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessibleNucleic Acids Research, 2016
- The human CD5L/AIM-CD36 axis: A novel autophagy inducer in macrophages that modulates inflammatory responsesAutophagy, 2015
- Inflammatory Stress Increases Hepatic CD36 Translational Efficiency via Activation of the mTOR Signalling PathwayPLOS ONE, 2014
- Lymphatic Endothelial Differentiation in Pulmonary Lymphangioleiomyomatosis CellsJournal of Histochemistry & Cytochemistry, 2013
- ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferationCellular Signalling, 2013
- Coagulation Cascade Proteinases in Lung Injury and FibrosisProceedings of the American Thoracic Society, 2012
- Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependentProceedings of the National Academy of Sciences, 2011
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Research, 2008
- The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytesMetabolism, 2007
- Mutations in the tuberous sclerosis complex geneTSC2are a cause of sporadic pulmonary lymphangioleiomyomatosisProceedings of the National Academy of Sciences, 2000